Topical Application of Latanoprost in Diabetic Retinopathy
- Registration Number
- NCT01225653
- Lead Sponsor
- University of Aarhus
- Brief Summary
Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.
- Detailed Description
The primary objective is to study if a sustained contraction of pathologically dilated retinal arterioles can be obtained. Retinal arteriolar diameter and the diameter response to increased blood pressure is studied using the Dynamic Vessel Analyzer (Imedos, Germany.
The secondary objective is to study whether the intervention can halt the development of diabetic retinopathy, which is assessed by optical coherence tomography (OCT) scanning and fundus photography.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- Age 20-36 years old
- Diabetes mellitus with retinopathy
- Pregnancy
- Previous ocular disease other than diabetic retinopathy
- General disease with possible influence on the eye
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Latanoprost Latanoprost Topical treatment with latanoprost Placebo Latanoprost Placebo arm
- Primary Outcome Measures
Name Time Method The diameter of retinal arterioles 24 months The diameter of retinal arterioles will be assessed using the Dynamic Vessel Analyzer
- Secondary Outcome Measures
Name Time Method The severity of diabetic retinopathy 24 months Severity of diabetic retinopathy will be measured by optical coherence tomography (OCT) scanning and fundus photography
Trial Locations
- Locations (1)
Department of Ophthalmology, Århus University Hospital
🇩🇰Århus, Denmark